Is there a risk of cancer development after Campylobacter infection?

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 7-8, 2010, Pages 893-897

  Brauner, Annelie ^a   Brandt, Lena ^a   Frisan, Teresa ^a   Thelestam, Monica ^a   Ekbom, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Campylobacter jejuni; cancer; cohort study; epidemiology

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAMPYLOBACTERIOSIS; CANCER RISK; CARCINOGENESIS; CHILD; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; GASTROINTESTINAL TRACT; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHILD; CHILD, PRESCHOOL; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS;

EID: 77955695821     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521003734133     Document Type: Article

References (17)

1. Altekruse SF, Stern NJ, Fields PI, Swerdlow DL. Campylobacter jejuni-an emerging foodborne pathogen. Emerg Infect Dis 1999;5:28-35.
2. World Health Organization The increasing incidence of human campylobacteriosis. World Heath Organization, Geneva, Switzerland; 2001, pp 19-25.
3. Martinez I, Mateo E, Churruca E, Girbau C, Alonso R, Fernández- Astorga A. Detection of cdtA, cdtB, and cdtC genes in Campylobacter jejuni by multiplex PCR. Int J Med Microbiol 2006;296:45-48
4. Frisan T, Cortes-Bratti X, Chaves-Olarte E, Stenerlöw B, Thelestam M. The Haemophilus ducreyi cytolethal distending toxin induces DNA double-strand breaks and promotes ATM-dependent activation of RhoA. Cell Microbiol 2003;5:695-707.
5. Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004;350:239-248 (Pubitemid 38067636)
6. Mattsson B, Wallgren A. Completeness of the Swedish cancer register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-313
7. Lax AJ. Opinion: bacterial toxins and cancer-a case to answer? Nat Rev Microbiol 2005;3:343-349
8. Adami J, Gäbel H, Lindelöf B, Ekström K, Rydh B, Glimelius B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003;89:1221-1227
9. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a metaanalysis. Lancet 2007;370:59-67.
10. Samuelsson SM, Ekbom A, Zack M, Helmick CG, Adami HO. Risk factors for extensive ulcerative colitis and ulcerative proctitis: a population based case-control study. Gut 1991;32:1526-1530
11. Suman S, Williams EJ, Thomas PW, Surgenor SL, Snook JA. Is the risk of adult coeliac disease causally related to cigarette exposure? Eur J Gastroenterol Hepatol 2003;15:995-1000.
12. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet 2009;374:477-490
13. Amin J, Dore GJ, O'Connell DL, Bartlett M, Tracey E, Kaldor JM, et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 2006;45:197-203.
14. Watanapa P, Watanapa WB. Liver fluke-associated cholangiocarcinoma. Br J Surg 2002;89:962-970
15. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006;118:1591-1602
16. O'Leary J, Corcoran D, Lucey BJ. Comparison of the EntericBio multiplex PCR system with routine culture for detection of bacterial enteric pathogens. J Clin Microbiol 2009;47: 3449-3453
17. Janssen R, Krogfelt KA, Cawthraw SA, van Pelt W, Wagenaar JA, Owen RJ. Host-pathogen interactions in Campylobacter infections: the host perspective. Clin Microbiol Rev 2008;21:505-518